Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma.
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary)
- Indications Neuroblastoma
- Focus Adverse reactions
- Acronyms RICE-NK
- 10 Jun 2017 Biomarkers information updated
- 18 Jan 2011 Planned initiation date changed from 1 Sep 2010 to 1 Sep 2011 according to ClinicalTrials.gov.
- 14 Jul 2010 New trial record